Patients classified as Type 3 exhibited the most unfavourable characteristics: low BMI and haemoglobin levels, high platelet counts, elevated CEA and PLR values, and advanced tumour stage (TNM IIIC). This evidence concerns the gene CEACAM5 and neoplasm.